Radical prostatectomy and robotic radiosurgery as treatment options for localized prostate cancer

Автор: Kipriyanov Evgeny A., Karnaukh Peter A., Vazhenin Ilya A., Vazhenin Andrey V.

Журнал: Сибирский онкологический журнал @siboncoj

Рубрика: Клинические исследования

Статья в выпуске: 1 т.19, 2020 года.

Бесплатный доступ

Purpose: to compare immediate, short-term and long-term treatment outcomes after radical prostatectomy and robotic radiosurgery in patients with localized prostate cancer. Material and Methods. The study included 2 groups of patients. Group I patients (n=80) underwent radical surgery (nerve-sparing prostatectomy). Group II patients (n=102) underwent KiberKnife stereotactic robotic radiotherapy. Results. Immediate treatment outcomes after both radical prostatectomy and robotic radiosurgery did not demonstrate increased number of postoperative complications and severe radiation-induced injuries. The PSA level decreased and reached a nadir PSA level immediately after radical prostatectomy. After stereotactic radiation therapy, the PSA level decreased gradually every three months, reaching a nadir within a year. In the group of patients receiving CyberKnife treatment, changes in the prostate volume affected the quality of urination, which was confirmed by the assessment of the volume of residual urine. When comparing the quality of urination in treatment groups using the IPSS scale, the values were comparable. No differences in the 1-year disease-free survival rates between groups were found. However, 60 months later, disease free survival rate was higher by 8.2 % in patients treated with radiosurgery than in patients who underwent radical prostatectomy (p function show_abstract() { $('#abstract1').hide(); $('#abstract2').show(); $('#abstract_expand').hide(); }

Еще

Prostate cancer, radical prostatectomy, robotic radiosurgery, kiberknife

Короткий адрес: https://sciup.org/140254052

IDR: 140254052   |   DOI: 10.21294/1814-4861-2020-19-1-50-56

Список литературы Radical prostatectomy and robotic radiosurgery as treatment options for localized prostate cancer

  • Важенин А.В., Карнаух П.А. Эпидемиология рака предстательной железы в Челябинской области. Паллиативная медицина и реабилитация. 2008; 2: 26-28.
  • Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). М., 2017. 250 с.
  • Гришина Ю.А., Хмелевский Е.В. Лучевая терапия локальных рецидивов рака предстательной железы после радикальной простатэктомии. Вопросы онкологии. 2015; 61(1): 7-13.
  • Hegemann N.S., Guckenberger M., Belka C., Ganswindt U., Manapov F., Li M. Hypopofractionated radiotherapy for prostate cancer. Radiat Oncol. 2014 Dec 6; 9: 275. DOI: 10.1186/s13014-014-0275-6
  • Pedicini H., Strigari L., Benassi M. Estimation of a self of radio-biological parameters from hypofractionated versus standartd radiation therapy of prostate cancer. Int J Radiat Oncol Biol Phys. 2013 Apr 1; 85(5): e231-7. DOI: 10.1016/j.ijrobp.2012.11.033
  • Sanfilippo N.J., Cooper B.T. Hypofractionated radiation therapy for prostate cancer: biologic and technical considerations. Am J Clin Exp Urol. 2014 Dec 25; 2(4): 286-93.
  • Katz A.J., Kang J. Stereotactic body radiotherapy as treatment for organ confined low- and intermediate-risk prostate carcinoma, a 7-year study. Front Oncol. 2014 Sep 2; 4: 240. DOI: 10.3389/fonc.2014.00240
Еще
Статья научная